J Tujakowski Selected Research

Stomatitis

12/2003

Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Tujakowski Research Topics

Disease

2	Colorectal Neoplasms (Colorectal Cancer) 12/2003 - 07/2003
2	Neutropenia 12/2003 - 07/2003
1	Nausea 12/2003
1	Febrile Neutropenia 12/2003
1	Alopecia (Baldness) 12/2003
1	Carcinoma (Carcinomatosis) 12/2003
1	Colonic Neoplasms (Colon Cancer) 12/2003
1	Diarrhea 12/2003
1	Vomiting 12/2003
1	Sepsis (Septicemia) 12/2003
1	Hand-Foot Syndrome 12/2003
1	Stomatitis 12/2003
1	Cross Infection (Nosocomial Infection) 01/2001
1	Bacteremia 01/2001

Drug/Important Bio-Agent (IBA)

2	Leucovorin (Folinic Acid)FDA Link 12/2003 - 07/2003
2	Fluorouracil (Carac)FDA LinkGeneric 12/2003 - 07/2003
1	Capecitabine (Xeloda)FDA Link 12/2003
1	Irinotecan (Camptosar)FDA LinkGeneric 07/2003
1	ElementsIBA 01/2001

Therapy/Procedure

2	Therapeutics 12/2003 - 07/2003
1	Drug Therapy (Chemotherapy) 12/2003